Raleigh, NC - Vaccine developer Arbovax Inc. has closed its Series A round with a total investment of $1.43 million, led by Piedmont Angel Networks with additional investment from The Research Development Foundation, Carson City, Nevada and Mario Family Partners. (more…)

PRINCETON, N.J.– Battelle Ventures, LP, has spun out regenerativemedicine start-up NellOne Therapeutics, Inc. (NellOne), from the U.S. Department of Energy’s Oak Ridge National Laboratory (ORNL), with an initial $1.5-million seed
investment from the fund and its Tennessee affiliate, Innovation Valley Partners.The investment will be tranched based on key technical milestones. (more…)

ALACHUA, FL - Oragenics Inc. (ONI BioPharma Inc.) (AMEX: ONI) has entered into a definitive financing agreement providing for equity financing of $2,600,000 consisting of common stock at 45 cents per share and warrants with an exercise price of $1.30 per share. (more…)

Richmond, VA. USA / Rosh Ha’Ayin, Israel, June 2nd, 2008 – EnzySurge Ltd. (EnzySurge), a provider of innovative solutions for advanced chronic wound management, announced today that it successfully completed its latest round of funding of US $4 million. The round was extended from $2 million, as was announced on January 2008, to $4 million and was led by Eli Gilboa from Gilboa&Licht, who is the company’s chairman. To date, the company has raised a total US$7.3 million. With this additional capital, the company will be positioned to execute on its plan to commercialize its products, for market launch in early 2009. The addressable market for DermaStream™ advanced wound care products is estimated by industry analysts to be US$6 billion. (more…)